Skip to Main Content

Author Details

Jos?? Palacios
Universidad de Alcala
1983
299
69
PMIDPaper TitleJournal TitlePublished Year
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
37446361The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).Int J Mol Sci2023
36980575Evaluation of <i>ERBB2</i> mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases.Cancers (Basel)2023
35173701RNA SARS-CoV-2 Persistence in the Lung of Severe COVID-19 Patients: A Case Series of Autopsies.Front Microbiol2022
35352148Impact of the COVID-19 pandemic on pathology training: a survey among Spanish residents.Virchows Arch2022
35691726Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations.Pathology2022
36405615Progression to lung fibrosis in severe COVID-19 patients: A morphological and transcriptomic study in postmortem samples.Front Med (Lausanne)2022
36579549Laboratory Cross-Comparison and Ring Test Trial for Tumor <i>BRCA</i> Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.J Pers Med2022
36305536Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).Int J Gynecol Pathol2022
35877198The Clonal Relationship Between the Ductal and Lobular Components of Mixed Ductal-Lobular Carcinomas Suggested a Ductal Origin in Most Tumors.Am J Surg Pathol2022
33722841Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore.J Clin Pathol2022
35131080Acute Dyspnea and Hemoptysis in an 84-Year-Old Man With Multiple Comorbidities.Chest2022
35156343Cytological and molecular characterization of secretory breast carcinoma.Diagn Cytopathol2022
35281099Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the <i>in vivo</i> Biological Context.Front Cell Dev Biol2022
35124717Comparison of the Idyllaâ¿¢ MSI assay with the Promegaâ¿¢ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study.Virchows Arch2022
34908168Immune-related gene expression signatures: a step forward in the stratification of patients with ovarian clear cell carcinoma<sup>â¿ </sup>.J Pathol2022
35267459Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases.Cancers (Basel)2022
32896442Reflections on the need for Nephropathology Reference Units.Nefrologia (Engl Ed)2021
36165356Reflections on the need for Nephropathology Reference Units.Nefrologia (Engl Ed)2021
33758071Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study.Thorax2021
34722679Late Cardiac Pathology in Severe Covid-19. A Postmortem Series of 30 Patients.Front Cardiovasc Med2021
34572945Reproducibility of mRNA-Based Testing of <i>ESR1</i>, <i>PGR</i>, <i>ERBB2</i>, and <i>MKI67</i> Expression in Invasive Breast Cancer-A Europe-Wide External Quality Assessment.Cancers (Basel)2021
34771579Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis.Cancers (Basel)2021
34299016Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma.Int J Mol Sci2021
33963008Tumor mutational burden assessment in non-small-cell lung cancer samples: results from the TMB<sup>2</sup> harmonization project comparing three NGS panels.J Immunother Cancer2021
34296539LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology.Cancer Med2021
33435234Molecular Heterogeneity of High Grade Colorectal Adenocarcinoma.Cancers (Basel)2021
33252403Vulvar Pilomatrix Carcinoma: Morphologic and Molecular Features.Int J Gynecol Pathol2021
31498173The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO).Am J Surg Pathol2020
32045050The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407).Oncologist2020
31797087Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).Virchows Arch2020
33240438Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications.EJC Suppl2020
32664968Next generation sequencing to decipher concurrent loss of PMS2 and MSH6 in colorectal cancer.Diagn Pathol2020
32650408Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma.Cancers (Basel)2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32549380Low Prevalence of HER2-Positive Breast Carcinomas among Screening Detected Breast Cancers.Cancers (Basel)2020
32384322Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.Am J Surg Pathol2020
32294063Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and Consequences.Am J Surg Pathol2020
30641862High Frequency of <i>ERBB2</i> Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features.Cancers (Basel)2019
31530406[Clinical challenges and implications of intratumor heterogeneity].Rev Esp Patol2019
31324031Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma.Cancers (Basel)2019
31064780Intracellular Delivery of an Antibody Targeting Gasdermin-B Reduces HER2 Breast Cancer Aggressiveness.Clin Cancer Res2019
30931249Efficacy of immunotherapy in sarcomatoid lung cancer, a case report and literature review.Respir Med Case Rep2019
28815456Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.Clin Transl Oncol2018
29916189Correction to: Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.Clin Transl Oncol2018
30153845Pleomorphic lobular carcinoma of the breast with osteoclast-like giant cells: a case report and review of the literature.Diagn Pathol2018
30012308[Proposal of the SEOM, SEAP and SEFH for the creation of a National Strategy for Precision Medicine in Cancer].Rev Esp Patol2018
29984379Histological changes secondary to wire coil placement in breast tissue and lymph nodes.Virchows Arch2018
30062862Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2018
30337841Modified SureSelect<sup>QXT</sup> Target Enrichment Protocol for Illumina Multiplexed Sequencing of FFPE Samples.Biol Proced Online2018
  • 1 - 50 of 299

Recommended Authors

Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 10
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 3
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 0
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 3
University of Toronto.
Career Start Year 2001
Number of shared co-authors 54
Institute of Pathology, Paracelsus Medical University
Career Start Year 2000
Number of shared co-authors 0
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 5
Health Research Institute Hospital La Fe
Career Start Year 1999
Number of shared co-authors 1
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 5
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 0
University of Southern California
Career Start Year 1995
Number of shared co-authors 9
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 62
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 44
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 3
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1990
Number of shared co-authors 5
University of Michigan ann arbor
Career Start Year 1989
Number of shared co-authors 8
Oregon Health & Science University
Career Start Year 1989
Number of shared co-authors 103
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 13
Thomas Jefferson University Hospital
Career Start Year 1988
Number of shared co-authors 7
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 4
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 1
University of Kansas
Career Start Year 1985
Number of shared co-authors 0
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 6
The Norwegian Radium Hospital, Oslo University Hospital
Career Start Year 1980
Number of shared co-authors 6
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 2
University of Toronto
Career Start Year 1977
Number of shared co-authors 85
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 8
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 79

Collaborators

Instituto de Salud Carlos III
Co-authored papers 29
Memorial Sloan-Kettering Cancer Center
Co-authored papers 20
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 14
Spanish National Cancer Research Centre (CNIO)
Co-authored papers 12
Co-authored papers 10
The Institute of Cancer Research
Co-authored papers 9
University of Queensland
Co-authored papers 8
Co-authored papers 8
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Hospital del Mar Research Institute
Co-authored papers 7
UCSF Helen Diller Family Comprehensive Cancer Center
Co-authored papers 7
HM Hospitales-Centro Integral Oncologico Clara Campal
Co-authored papers 7
Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.
Co-authored papers 6
Co-authored papers 6
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 6
Co-authored papers 5
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 5
University of British Columbia
Co-authored papers 5
Otto-Friedrich-University Bamberg
Co-authored papers 5
University Hospital Fundacion Alcorcon
Co-authored papers 4
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 4
University of Vienna
Co-authored papers 4
University of Hawaii Cancer Center
Co-authored papers 4
Mayo Clinic College of Medicine
Co-authored papers 4
Westmead Hospital
Co-authored papers 4
University of Cambridge
Co-authored papers 4
David Geffen School of Medicine, University of California los angeles
Co-authored papers 4
University of Cambridge
Co-authored papers 4
Co-authored papers 4
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 4